Message from Our CEO
Thank you for your interest in Colorcon, Inc.
Privately owned, Colorcon is the world leader in the development, supply and technical support of formulated coatings and excipients for the pharmaceutical industry.
Colorcon’s overall vision is to earn the position of Supplier of Choice for pharmaceutical companies who develop and manufacture solid oral dosages (tablet, capsule or multiparticulate forms for immediate or modified release).
We aim to achieve that by continuously bringing more value to their business; providing technical and regulatory support during product development, helping lower the total cost in operations and making a positive contribution towards the quality of the end products. We work to excel by offering our customers the shortest possible lead times for commercial products, developmental samples, and regulatory documentation; delivering excellence with valued services. We strive to be a truly global partner by serving the development community and supply chain of the pharmaceutical industry in every corner of the world. The whole Colorcon organization works relentlessly to make it increasingly easier for our customers to work and do business with us.
If you are ready for the challenge of working for an exciting company in the environment where visibility is high and continuous improvement through employee empowerment and trust are key, then we encourage you to contact Colorcon.
Simon Tasker, CEO
Voice of Our Employees
Find out about a diverse team dedicated to one purpose: Make Colorcon the Supplier of Choice.
We have the career opportunities of big pharma in the atmosphere of a privately-owned company.
Message from Our CEO
On the role that employee empowerment plays in delivering steadfast value to customers.
Discover the six guiding principles that help Colorcon people support our mission and vision.
Infórmese sobre lo que sucede en Colorcon
Infórmese sobre innovación de nuevos productos y esté atento a las nuevas oportunidades para contactarse por medio de los webinars y los eventos de la industria.
- Nueva Edición - Solid Dose Diciembre 2020
- Press Release: Colorcon Ventures Invests in Innovative Biotech Company i2O Therapeutics
- Nueva Edición - Solid Dose Agosto 2020
- Press Release: Colorcon Ventures Invests in Industry Leading AI Provider for Drug Discovery Atomwise
- Press Release: Colorcon and TruTag Technologies Enter into Development Agreement Targeting Authentication of Medicines